There are 3 Rho A-specific GEFs have been found to control HA-mediated CD44 signaling during tumor cell activation: p115-RhoGEF, leukemia-associated RhoGEF (LARG), and PDZ-RhoGEF [97]. The gene discussed is ARHGEF12; the disease is neoplasm.